BQ-869

BQ-869 is an NMDA receptor antagonist related to dizocilpine (MK-801).

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

BQ-869 is an NMDA receptor antagonist related to dizocilpine (MK-801). It is described as a derivative of dizocilpine and has shown higher potency in comparison. The drug shows neuroprotective effects in rodents, for instance against stroke and cerebral ischemia.

It is described as being "extremely potent" and was said to be "the most potent antagonist of NMDA receptors". However, this was not based on standard affinity or functional assays for establishing potency. BQ-869 was described in the scientific literature by Guo Yu and colleagues in Shanghai, China in 2015.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1350501369 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.